Influence of Catechol-O-Methyltransferase (COMT) Val158Met Polymorphism in Conditioned Pain Modulation in Women with Migraine
Authors:
- Margarita Cigarán-MéndezMCMargarita Cigarán-Méndez
- Ana I. De-La-Llave-RincónADAna I. De-La-Llave-Rincón
- Juan C. Pacho-HernándezJPJuan C. Pacho-Hernández
- Angela Tejera-AlonsoATAngela Tejera-Alonso
- Cristina Gómez-CaleroCGCristina Gómez-Calero
- César Fernández-De-Las-PeñasCésar Fernández-De-Las-Peñas
- Lars Arendt-NielsenLALars Arendt-Nielsen
- Silvia Ambite-QuesadaSASilvia Ambite-Quesada
Open Access
- 4 June 2026
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (11) , 5107
Abstract
The role of the catechol-O-methyltransferase (COMT) Val158Met rs4680 polymorphism in altered pain processing in headaches is controversial. The aim of this study was to investigate the influence of the Val158Met rs4680 polymorphism in conditioned pain modulation (CPM) in women with migraine. A case-control study including 70 women with chronic migraine, 70 with episodic migraine and 70 pain-free women was conducted. Pressure pain thresholds (PPTs) at the temporalis muscle, lateral epicondyle, and tibialis anterior were bilaterally assessed. Heat (HPT) and cold (CPT) pain thresholds at the frontalis muscle were also assessed. Subsequently, CPM was evaluated immediately after a one-minute cold-pressor test paradigm on changes obtained in PPTs, HPT and CPT. Thus, after amplifying Val158Met polymorphism by polymerase chain reaction, genotype frequencies (Val/Val, Val/Met, or Met/Met) and allele distributions were identified. The distribution of Val158Met genotypes (p = 0.097) was not significantly different among women with episodic migraine, chronic migraine and pain-free controls. The results revealed significant group*time*Val 158Met interactions for PPTs at the temporalis (Wilk’s λ = 0.917, F [4, 193] = 4.377, p = 0.002, n2p = 0.083, 1 − β = 0.930) and lateral epicondyle (Wilk’s λ = 0.892, F [4, 193] = 5.870, p < 0.001, n2p = 0.108, 1 − β = 0.982), as well as CPT (Wilk’s λ = 0.872, F [4, 193] = 7.111, p < 0.001, n2p = 0.128, 1 − β = 0.995) or HPT (Wilk’s λ = 0.921, F [4, 193] = 4.133, p = 0.003, n2p = 0.079, β − 1 = 0.914), but not for the PPT at tibialis anterior (Wilk’s λ = 0.983, F [4, 193] = 0.834, p = 0.505, n2p = 0.017, 1 − β = 0.263). Women with chronic migraine with the Met/Met genotype exhibited reduced CPM indexes for PPT, CPT, or HPT at the temporalis (trigeminal area) than those with the Val/Val genotype. This study showed that CPM deficit is higher in women with migraine with the Met/Met genotype, but this association is mostly present in the symptomatic (trigeminal) area in the chronic form of the disease. No association of the Met/Met genotype with CPM was seen in healthy controls.Keywords
Funding Information
- Ilustre Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid y el Colegio Oficial de Farmacéuticos de Madrid
This publication has 38 references indexed in Scilit:
- Human assumed central sensitization in interictal migraine: a systematic review and meta-analysisNeurological Sciences, 2026
- What has neurophysiology revealed about migraine and chronic migraine?2023
- Are catechol-O-methyltransferase gene polymorphisms genetic markers for pain sensitivity after all? – A review and meta-analysisNeuroscience & Biobehavioral Reviews, 2023
- Different genes may be involved in distal and local sensitization: A genome‐wide gene‐based association study and meta‐analysisEuropean journal of pain, 2022
- Genetic variation in catechol‐O‐methyltransferase is associated with individual differences in conditioned pain modulation in healthy subjectsThe Journal of Gene Medicine, 2021
- A Comprehensive Review on the Role of Genetic Factors in the Pathogenesis of MigraineJournal of Molecular Neuroscience, 2021
- Recommendations on practice of conditioned pain modulation (CPM) testingEuropean journal of pain, 2014
- Recommendations on terminology and practice of psychophysical DNIC testingEuropean journal of pain, 2010
- Catechol- O -methyltransferase inhibition increases pain sensitivity through activation of both β2- and β3-adrenergic receptorsPain, 2007
- Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): Standardized protocol and reference valuesPain, 2006